Related by context. All words. (Click for frequent words.) 83 Completes Patient Enrollment 83 Initiates Phase II 81 Initiates Clinical Trial 80 Initiates Clinical 80 Initiates Enrollment 80 Initiates Phase III 80 Presents Positive 79 Successfully Completes Phase 79 Completes Enrollment 79 Submits Biologics License Application 79 Begins Dosing 78 Submits Response 78 Therapeutic Competitors Companies 78 Submits NDA 78 Initiates Dosing 77 Submits IND 77 Files IND 77 Receive Milestone Payment 77 Collaborators Present 77 Receives Milestone Payment 76 Presents Preclinical Data 76 Meets Primary Endpoint 76 Receives Orphan Drug Designation 76 Present Preclinical Data 75 Presents Preclinical 75 Reports Preclinical Data 75 Licenses Novel 75 Earns Milestone Payment 75 Announce Initiation 75 Inc Therapeutic Competitors 75 Announces Dosing 75 Announces Presentation 75 Submits Supplemental 74 Initiates Phase 74 BioSante Pharmaceuticals Announces 74 Vaccine Adjuvant 74 Phase 2b Clinical Trial 74 Receives Approvable Letter 74 Enrolls First 74 Receives Orphan Drug 74 Announce Collaboration Agreement 74 Demonstrates Significant 74 Announce License Agreement 74 Drug Candidate 74 FDA Okays 74 Clinical Trial Results 74 Therapeutic Competitors companiesandmarkets.com adEgemonye 74 Combination REOLYSIN R 73 IG HCR ;) CO 73 Achieves Primary Endpoint 73 Vaccine Protects Against 73 Commences Phase 73 pralatrexate injection folate analogue 73 Announces Poster Presentations 73 Reveals Positive 73 Gets FDA Clearance 73 Patent Covering 73 Receives Fast Track 73 Investigational Compound 73 Receives Tentative Approval 73 Drug Fails 73 Granted Orphan Drug 73 Announces Initiation 73 Collaborators Publish 73 Initiates Clinical Trials 73 FDA Clears 73 Initiate Phase III 73 R MSCRAMM 73 Inc. www.micromet inc.com 73 Patient Enrollment 72 Pivotal Phase III 72 Initiates Phase 2b 72 Lupus Drug 72 Develop Novel 72 First Patient Enrolled 72 Initiate Phase 72 Oral Calcitonin 72 Immunomedics Announces 72 JAK2 Inhibitor 72 Completes Patient Enrolment 72 TRACON Pharmaceuticals 72 Shows Promising 72 Announce Licensing Agreement 72 Namenda Memantine HCl 72 Receives NASDAQ 71 Phase 2b Trial 71 Phase 2a Trial 71 Systemic Delivery 71 Mylan Receives Approval 71 Abstract Accepted 71 Epilepsy Drug 71 Presents Positive Preclinical 71 FDA Accepts 71 Files Shelf Registration Statement 71 PRN FDA Approves 71 Confirms Efficacy 71 Drug Shows Promise 71 NDA Submission 71 Jumps Higher 71 Demonstrates Positive 71 Announce Merger Agreement 71 Files Investigational 71 Announces Tentative Approval 71 Shows Promise Against 71 Preclinical Data 71 Commences Phase III 71 Demonstrates Potential 71 Teva Provides Update 71 Files Patent Application 71 Shows Efficacy 71 visit http:/www.mannkindcorp.com 71 Anti Tumor 71 Improves Survival 71 OTC BB PVCT 71 Successfully Treats 71 Patent Issued 71 Nasdaq XTLB 71 Therapeutic Competitors 71 Prolongs Survival 70 Submits Application 70 Begins Shipment 70 Preclinical Study 70 Receives Patent 70 Lung Cancer Drug 70 please visit http:/www.vandapharma.com 70 Licenses Patents 70 Corp. AMEX CVM 70 Sign Licensing Agreement 70 Xcytrin R 70 Nasdaq AEGR 70 Osteoporosis Drug 70 Initiate Clinical Trial 70 Crofelemer budesonide foam 70 Antitumor Activity 70 Phase IIb Clinical Trial 70 Receives Complete Response 70 Inc. Nasdaq OXGN 70 Arthritis Drug 70 please visit www.medicinova.com 70 Receives Favorable 70 Obtains Exclusive License 70 Aeolus Pharmaceuticals Announces 70 MBRX 70 Hsp# Inhibitor 70 please visit http:/www.atherogenics.com 70 Genentech Wyeth Pharmaceuticals 70 Metastatic Melanoma 70 Cervical Dysplasia 70 PHRM 70 Novel Oral 70 Phase IIb Trial 70 Tech DVAX 70 Advanced Melanoma 70 Sinks Lower 70 Launches Generic Version 70 programs visit http:/www.bionovo.com 70 visit www.genenews.com 70 Prostate Cancer Vaccine 70 Milestone Payment 70 www.micromet inc.com 69 NASDAQ MNKD focuses 69 Phase III Clinical Trial 69 Nasdaq MNKD focused 69 Nasdaq MNKD focuses 69 Phase III Trial 69 MEK Inhibitor 69 pharmacogenomic translational research 69 Severe Sepsis 69 Gout Drug 69 Pegloticase 69 Announces FDA Clearance 69 IND Filing 69 NASDAQ PCYC Niusule 69 Extends Collaboration 69 Xoma Ltd 69 please visit http:/www.supergen.com 69 RNAi Therapeutic 69 Receives CE Marking 69 FDA Approvals 69 Taglich Brothers Initiates Coverage 69 Significantly Improves 69 Test Detects 69 platform HDL Mimetic 69 Announces Issuance 69 recurrent metastatic ovarian cancer 69 Novel Antibiotic 69 Patients Treated With 69 Regains NASDAQ 69 Improves Outcomes 69 Reports Positive 69 Awarded Qualifying Therapeutic 69 Study Evaluating 69 oncolytic virus therapies 69 please visit www.dyax.com 69 Enters Into Collaboration 69 Rheumatoid Arthritis Drug 69 FOLOTYN ® 69 Genentech sanofi aventis 69 Receives FDA Clearance 69 Adjuvant Treatment 69 website http:/www.celsion.com 69 Unanimously Recommends Approval 69 Fast Track Status 69 Voluntarily Withdraw 69 Commence Phase 69 Reduces Risk 69 Small Molecule 69 Rotavirus Vaccine 69 MKC# MT 69 Immunotherapeutic 69 Tyrosine Kinase Inhibitor 69 IND Application 69 Pivotal Phase 69 Transdermal Patch 69 Successfully Treated 69 HCV Protease Inhibitor 69 Demonstrates Sustained 69 Webcast Presentations 69 Novel Therapeutic 69 Announces License Agreement 69 Oral Fingolimod 69 Investigational Treatment 69 Inc. OTCBB MBCI 68 Milestone Payment From 68 Nicotine Vaccine 68 Commercialize Novel 68 Identifies Potential 68 Inc FRX FRX 68 Inc SPPI 68 candidates Azedra TM 68 website www.celsion.com 68 GNSZ 68 ASE SVA 68 Taro Receives 68 Smallpox Vaccine 68 Obtains Approval 68 Guidelines Issued 68 visit http:/www.neogenomics.org 68 Inc. NASDAQ SIRT 68 Awarded Patents 68 Phase 1b Clinical Trial 68 highly purified pasteurized 68 Announces Licensing Agreement 68 Biogen Genentech 68 Sangamo BioSciences Announces 68 lead molecular radiotherapeutic 68 Dose Ranging 68 Nasdaq EPCT 68 Cholesterol Lowering Drug 68 Regains Full 68 Terminate Merger Agreement 68 Oral Laquinimod 68 Demonstrates Potent 68 visit http:/www.PAREXEL.com 68 Diabetic Foot Ulcer 68 Personalized Immunotherapy 68 please visit http:/www.sunesis.com 68 Migraine Drug 68 Telik logo TELINTRA 68 Reacquires 68 Therapeutic Competitors Report 68 Nasdaq PGNX 68 Single Dose 68 Spectrum Pharmaceuticals Announces 68 OTCBB FCSC 68 Invites Investors 68 SIX RO ROG 68 NASDAQ MIPI 68 Drug Combo 68 Provides Update Regarding 68 Ltd Therapeutic Competitors 68 MONSTERSTOX.COM Monsterstox.com 68 Psoriasis Drug 68 Reduces Mortality 68 Vaccine Candidate 68 visit www.stemcellthera.com 68 Preclinical Models 68 Welcomes Analyst Initiation 68 Receives SFDA Approval 68 Inc. Nasdaq IMGN 68 STERIS Corporation Announces 68 PFE PFE 68 Inc NGSX 68 Treatment Shows Promise 68 Trial Evaluating 68 Idenix Novartis 68 developing Surfactant Replacement 68 Aradigm Logo 68 GVAX ® 68 Aethlon Medical Releases 68 Novel Vaccine 68 Phase III Pivotal 68 Settles Litigation 68 Bullish Average Crossover 67 Begins Clinical Trial 67 visit www.sciclone.com 67 Maven Semantic 67 developing adecatumumab 67 Antibody Drug Conjugate 67 Antiviral Drugs 67 AVI BioPharma Announces 67 Anemia Drug 67 NASDAQ ADLR 67 Corp. NASDAQ CYTR 67 NYSE SCR Simcere 67 Phase IIa Clinical Trial 67 please visit www.abraxane.com 67 Nasdaq CYCC Nasdaq CYCCP 67 Nasdaq ONXX 67 R lenalidomide 67 Ltd. OTCBB IMUC 67 Initiate Phase II 67 Randomized Phase II 67 By JENNIFER LEARN 67 Pivotal Study 67 Inc OSIP 67 Pharmacyclics Announces 67 Humanized Anti 67 Inc. ProMetic www.prometic.com 67 Nasdaq VNDA 67 MSCRAMM ® 67 Demonstrates Efficacy 67 website www.lipidsciences.com 67 GILD GILD 67 FDA APPROVES 67 FDA Approves Drug 67 Employment Inducement Awards 67 Alnylam Nasdaq ALNY 67 Alvine Pharmaceuticals 67 Files Provisional 67 http:/www.pharmacopeia.com 67 Vitrasert R 67 Study Demonstrates 67 Treatment Reduces 67 Bearish Average Crossover 67 Confirmatory Phase 67 Clinical Trial Evaluating 67 Valortim TM 67 VIVUS Announces 67 Kelly Luethje #-#-# 67 Amends Agreement 67 Colaris Colaris AP 67 HuMax TAC 67 Aztreonam Lysine 67 RNAi Therapeutics 67 Company website www.anormed.com 67 Gene Linked 67 Saegis Pharmaceuticals 67 Blood Pressure Drug 67 hyaluronidase enzyme 67 Recombinant Human 67 Study Shows Promise 67 PPD Declares 67 CysDisplay R 67 initiated Phase Ib 67 Boehringer Ingelheim MedImmune 67 Nasdaq AVNR 67 NasdaqGM SPPI 67 Inc. Nasdaq MITI 67 OTCBB HNAB 67 FDA Approves Novel 67 Inflammatory Disease 67 visit www.FRX.com 67 Dose Escalation 67 technology visit http:/www.genmab.com 67 Chronic Hepatitis B 67 Second Pivotal Phase 67 Receives Positive Opinion 67 Recommends Approval 67 Treating Chronic 67 Nasdaq ZGEN 67 AMEX RGN 67 Clinical Trial Data 67 Randomized Phase 67 Bullish Technical Alert 67 Nasdaq IDRA 67 IMiDs ® 67 Novartis Novo Nordisk 67 Pafuramidine 67 Kinase Inhibitor 67 Tumor Targeting 67 approved incretin mimetic 67 Therapeutic Antibody 67 Protease Inhibitor 67 Provides Guidance 67 Vaccine Shows Promise 67 Empatic ™ 67 Nasdaq AVNC 67 OTCBB IMUC 67 NASDAQ BIOD 67 www.pranabio.com 67 Retains CCG Investor Relations 67 Vicriviroc 67 Molecular Diagnostic Test 67 Brentuximab Vedotin SGN 67 Announces Underwriters Exercise 67 Amex PTN 67 Boxed Warnings 67 Nasdaq DVAX 67 By JAMAAL ABDUL 67 Pooled Analysis 67 Cyclacel Pharmaceuticals 67 interferon gamma 1b 67 Nuvelo Announces 67 Achieves Milestone 67 Mg Usa 67 Sign License Agreement 67 Sapacitabine 67 include Healive TM 67 Slows Progression 67 Data Suggest 67 www.syntapharma.com 67 Cypress Bioscience Inc 67 Company NASDAQ SKBI 67 Merck OSI Pharmaceuticals 67 Line Metastatic Colorectal 67 SPRYCEL ® 67 Canaccord Genuity Reiterates Buy 67 please visit www.advaxis.com 67 TO AVOID PREGNANCY WHILE 67 Cholesterol Drug 67 INSPIRE Trial Phase III 67 R Saizen R 67 non nucleoside inhibitor 67 please visit www.eisai.com 67 First Patient Dosed 67 Oral Formulation 67 CEFF financings subject 67 Multiple Ascending Dose 66 advanced compound INCB# 66 Board Authorizes 66 website http:/www.sinovac.com 66 www.nmtmedical.com 66 Nasdaq HALO 66 Shows Promise 66 Hormone Refractory Prostate Cancer 66 Pharma Merck Serono 66 Naglazyme R 66 Levels Linked 66 Effectively Treats 66 TransVax ™ 66 CD# CEA 66 Tezampanel 66 Issued Patent 66 ARRY # 66 DARA logo 66 Investigational Drug 66 Bradmer Pharmaceuticals 66 Announce Commencement 66 Double Blind Placebo 66 Anti Tumor Activity 66 Attracting Bullish Investors 66 Further Validates 66 Randomized Double Blind 66 Kaydon Corporation Announces 66 Ebola Vaccine 66 Expands Scientific Advisory 66 Proves Effective 66 Announces Postponement 66 Statin Drugs 66 includes TOLAMBA TM 66 NewsBite Downgrade Puts Pressure 66 FDA Approves 66 Successfully Completes Tender Offer 66 Multicenter Phase 66 Earnings Postmortem 66 Chemotherapeutic Agents 66 Nasdaq IMGN 66 Study Shows Benefits 66 Announces Successful Completion 66 Previously Treated 66 Tibotec BVBA 66 Hematological Cancers 66 manufactures minimally invasive 66 TransVax TM 66 Phase III Trials 66 Schizophrenia Drug 66 Randomized Double blind 66 Liprotamase 66 Regenerative Cell 66 FDA Approves Generic 66 TM Aganocide 66 www.vivus.com 66 Targanta Therapeutics Corporation 66 4SC AG ISIN DE# 66 Hematological Malignancies 66 Generic Versions 66 J.P. Morgan Healthcare 66 Receives Favorable Ruling 66 Finalizes Purchase 66 Paris IPN Euronext 66 Diamyd Medical Diamyd 66 molecular chaperone regulation 66 OTCBB ILNS 66 Inc. OTCBB BCLI 66 novel emulsion formulation 66 Myriad logo BRACAnalysis 66 Secures Financing 66 Study Showed 66 Dose Ranging Study 66 HDAC Inhibitor 66 Lanthanum Carbonate 66 markets COLAZAL 66 Drug Resistant 66 pentadentate logo R 66 Orally Active 66 Explore Strategic Alternatives 66 Settle Patent Litigation 66 Inc FRX 66 Slow Progression 66 Malaria Vaccine 66 Shingles Vaccine 66 Bucindolol Based 66 Announces Cancellation 66 AMEX KAL 66 http:/www.cytrx.com 66 Vildagliptin 66 Skymark Research Initiates Independent 66 Prostate Cancer Patients 66 Chronic Hepatitis C 66 Demonstrates Statistically Significant 66 Patients Receiving 66 Combination Treatment 66 Nasdaq CYTX 66 AAG geldanamycin analog 66 label Lipofen R 66 Nasdaq OSIP 66 products MKC# PP 66 www.cellgenesys.com 66 Projected Release Date 66 Enzon Pharmaceuticals Inc 66 Luveris R Ovidrel R 66 Holds Promise 66 visit www.targanta.com 66 Desvenlafaxine Succinate 66 Founding Scientist 66 Receives Notification 66 LymphoStat B belimumab 66 Announce Collaboration 66 Appears Safe 66 www.qiagen.com 66 Predict Risk 66 Gets Bearish Confirmation 66 OTCBB URGP specialty 66 DOR BioPharma Announces 66 Submits Investigational 66 TKB# 66 NASDAQ VPHM 66 Shows Statistically Significant 66 OTCBB CAEH 66 MOVIPREP R 66 www.hanabiosciences.com 66 RealPennies.com RealPennies.com 66 Inc. Amex PIP 66 Merck Serono Nycomed 66 JAK Inhibitor 66 Elagolix 66 product platforms AZX# 66 Canaccord Genuity Maintains Hold 66 Dyax logo 66 memantine HCl 66 CYT# potent vascular disrupting 66 Hematology Molecular Pathology 66 Renal Cancer 66 visit http:/www.martek.com 66 Clinical Study Shows 66 Lorus Therapeutics Announces 66 Consummates 66 Genes Linked 66 Successfully Concludes 66 Inc. OTCBB VYTR 66 Reduced Risk 66 Patient Enrolment 66 molecular therapeutics immunotherapies 66 Antitumor 66 Protein Biomarkers 66 NASDAQ ENMD 66 Study Confirms 66 Nasdaq TARG 66 Potelligent Technology 66 www.combinatorx.com 66 Flamel Technologies Announces 66 Updates Guidance 66 Receives Marketing Authorization 66 please visit www.sucampo.com 66 Metabolic Disorder 66 Genes Identified 66 Phase 2a Clinical Trial 66 Nanophase Announces 66 Oral Interferon 66 Biomarker Study 66 estrogen receptor beta agonist 66 product candidate Lpathomab 66 Novel Treatments 66 Calls Purchased 66 NASDAQ AVNR 66 Achillion Pharmaceuticals Inc 66 Salix Pharmaceuticals Announces 66 Nasdaq SCLN 66 Puts Purchased 66 Nasdaq CTIC 66 evaluating bafetinib 65 visit www.genmab.com 65 Tramiprosate ALZHEMED TM 65 Bearish Speculation 65 Maribavir 65 Helps Predict 65 candidates Azedra 65 Transcept Pharmaceuticals 65 Study Indicates 65 visit www.PAREXEL.com 65 Strengthens Balance Sheet 65 Patients Enrolled 65 includes Dideco CarboMedics 65 TRANSDUR ® 65 Diabetic Neuropathy 65 Pivotal Trials 65 Benzinga Volume Movers 65 Adjunctive Therapy 65 OTCBB PYTO 65 Darinaparsin 65 Announce Definitive Agreement 65 Announces Positive 65 Refractory Hodgkin Lymphoma 65 Topline Results 65 INDICATED LOWER 65 www.telik.com 65 Metabolic Disease 65 Telik Announces 65 UGNE 65 Demonstrate Significant 65 targeted anticancer biopharmaceuticals 65 Therapeutic Vaccine 65 proprietary intranasal insulin 65 PROLOR Biotech Inc. 65 Recurrent Breast Cancer 65 Announces Effective Date 65 Hepatocellular Carcinoma 65 Stem Cell Treatment 65 Budesonide foam crofelemer 65 Begin Clinical Trials 65 candidate XP# 65 vapreotide acetate 65 Inhaled Insulin 65 Drug Prevents 65 www.oxigene.com 65 OTC BB PVCT http:/www.pvct.com 65 reduce serum phosphate 65 Nasdaq CLDX 65 telomerase therapeutic 65 Femring ® 65 Matrix Phase 2b 65 Trastuzumab DM1 65 Safinamide 65 Pivotal Phase II 65 Phase #b/#a clinical 65 Receives Notice Related 65 BIOTECHNOLOGY SOURCE 65 Treatment Naïve 65 developing Zerenex ferric 65 Rigel R# 65 Seasonal Influenza Vaccine 65 particularly SANCTURA XR 65 NASDAQ REGN 65 Rotavirus Vaccines 65 TELINTRA R 65 albiglutide 65 Generic Version 65 Hold Fourth Quarter 65 Deliver Presentation 65 Hospital Acquired Pneumonia 65 website www.depomedinc.com 65 Improve Survival 65 dependent kinase inhibitor 65 Pending Acquisition 65 Metastatic Colorectal Cancer 65 novel proprietary KL4 65 equine osteoarthritis marketed 65 http:/www.sunesis.com 65 Resistant Hypertension 65 Finalizes Acquisition 65 Investigational Oral 65 methylnaltrexone bromide 65 Inc. NASDAQ AGIX 65 NASDAQ EMIS 65 Randomized Study 65 induced mucositis 65 Atypical Hemolytic Uremic Syndrome 65 PFE Short Term 65 NGSX 65 Announces Discontinuation 65 Disease Modifying 65 Receives Clearance 65 Gastric Cancer 65 Completes Tender Offer 65 Sunesis Pharma 65 CNS Disorders 65 VentiRx Pharmaceuticals 65 Receives Unsolicited 65 NASDAQ XTLB 65 Infected Patients 65 IIa Clinical Trial 65 Perifosine KRX 65 developing ACAPODENE 65 Monoclonal Antibody 65 Relapsing Multiple Sclerosis 65 Plaque Psoriasis 65 Multiple Sclerosis Rheumatoid Arthritis 65 Miraculins Announces 65 Redhotpennystock.com Alert 65 Pulmonary Arterial Hypertension 65 www.holliseden.com 65 Synthetic Peptide 65 OTCBB GNTA 65 Proven Effective 65 Nasdaq PARD 65 Transplant Patients 65 MKC# 65 Inc AMGN AMGN 65 Veronate R 65 NYSE Amex PBTH 65 ATRA IV 65 please visit www.dsi.com 65 www.cerus.com 65 Visit www.BASInc.com 65 DVAX 65 Hepatitis B Vaccine 65 agonistic human 65 Medarex logo 65 Mg Uk 65 OTCBB NNVC 65 Bazedoxifene 65 http:/www.viropharma.com 65 Pivotal Clinical Trial 65 Oracea TM 65 Completes Previously Announced 65 Inc GHDX 65 TSRX 65 Nasdaq NPSP 65 kidney urologic 65 PDL BioPharma Announces 65 Therapeutic Antibodies 65 Emtriva Viread 65 Therapeutic Efficacy 65 Bosutinib 65 Optimer Pharmaceuticals Inc 65 Anthracycline 65 website http:/www.depomed.com 65 Adjuvanted 65 Hypertensive Patients 65 Gentium Announces 65 Upcoming Conferences 65 sanofi aventis Bayer Schering 65 Adipose Derived Stem Cells 65 First Patient Treated 65 BNVID 65 MCSP respectively 65 Nasdaq THLD 65 Anticancer Drug 65 Closes Previously Announced 65 Successfully Closes 65 BCLI 65 TRIOLEX ™ 65 ThermoDox ® clinical 65 Vertex Pharmaceuticals Announces 65 acetonide FA 65 humanized therapeutic 65 Nasdaq Deficiency Notice 65 Archexin 65 otcstockexchange.com 65 hypoxia activated prodrug 65 Inhaled Liposomal Ciprofloxacin 65 Issues Guidance 65 Bird Flu Vaccine 65 Accelrys Announces 65 Pivotal Trial 65 OTCStockExchange.com Stock Alert 65 PharmaVitae Profile 65 TriCo Bancshares Announces 65 Significantly Reduces 65 Node Positive 65 Hold Third Quarter 65 Exercises Option 65 International www.iscointl.com 65 Post Earnings Checkup 65 Acute Exacerbations 65 candidate deforolimus 65 Frankfurt XMP 65 affiliate Evogene Ltd. TASE 65 BIIB BIIB 65 Osteoporosis Treatment 65 Aurora Kinase 65 Nasdaq CYCC 65 Anti CD# Antibody 65 Soft Tissue Sarcoma 65 CybeRelease Decliners 65 Selective Electrochemical Tumor Ablation 65 Generic Version Of 65 Secondary Hyperparathyroidism 65 ALPMF 65 Provectus Pharmaceuticals specializes 65 Milestone Payments 65 AFREZZA TM 65 Newly Diagnosed Multiple Myeloma 65 Study Validates 65 Pruvel TM 65 Survival Benefit 65 Endometrial Cancer 65 symbol AVXL 65 Progressive Multifocal Leukoencephalopathy 65 NICE Recommends 65 Inc. OTCBB ALRX 65 Exelixis logo 65 Nasdaq IMMU 65 Geokinetics Announces 65 Nasdaq NBIX 65 Long Term Efficacy 65 GlaxoSmithKline MedImmune 65 candidate Hematide TM 64 Fungal Infections 64 Receives Commitment 64 Restructures Debt 64 Senomyx Inc SNMX 64 NASDAQ VRTX 64 Novartis Organon 64 website www.novavax.com 64 NASDAQ KERX 64 CYP#A# substrate 64 Romiplostim 64 Advanced Renal Cell 64 Antibody Discovery 64 Am J Obstet 64 Report companiesandmarkets.com adds 64 non porcine pancreatic 64 Voluntarily Withdraws 64 Influenza Vaccine 64 www.combimatrix.com 64 company website www.novavax.com 64 Adjuvant Chemotherapy 64 website www.depomed.com 64 www.biosite.com 64 peptidic compound 64 Vitamin D analogue 64 CCR5 mAb 64 Advanced Colorectal Cancer 64 GERD migraine headaches 64 Receives Approvals 64 Pancreas Cancer Vaccine 64 Immune Cells 64 OTCBB DORB 64 OLGX 64 humanized interleukin 6 64 Vidaza R 64 Combo Therapy 64 Well Tolerated 64 Nasdaq ACAD 64 Expanded Indication 64 Corp. Nasdaq BSTC 64 Tuberculosis Vaccine 64 Late Breaker 64 Cephalon GlaxoSmithKline 64 Recombinant Protein 64 IAGX 64 oral ghrelin agonist 64 anti botulism antibody 64 Healthbeat Report 64 GATTEX TM 64 Autoimmune Diseases 64 Gamunex C 64 Non Invasive Treatment 64 Antigen Specific 64 palonosetron hydrochloride Injection Dacogen 64 Blood Thinner 64 Demonstrated Significant 64 Preclinical Efficacy 64 Complicated Skin 64 Cancer Vaccines 64 www.nymox.com email info@nymox.com 64 Secures Funding 64 personalized cellular immunotherapy 64 Explores Strategic Alternatives 64 NASDAQ BMRN 64 AUDIO PROVIDED BY 64 PEG irinotecan 64 Inovio Pharmaceuticals 64 Inc. Nasdaq MAXY 64 include ClindaReach TM 64 Subsidiary Enters 64 Plc Ads SHPGY 64 Supernus Pharmaceuticals 64 Drug Maker 64 http:/www.vical.com 64 NASDAQ SNTA 64 FDA Panel Recommends 64 ENABLE Phase 2 64 Inc. OTCBB CAXG 64 Nasdaq ENMD 64 Medicure Announces 64 Hemodialysis Patients 64 ALTROPANE R 64 Asthma COPD 64 NYSE PFE Exelon Rivastigmine 64 Testosterone Gel 64 www.incyte.com 64 Inc. NASDAQ MITI 64 Pandemic Influenza Vaccines 64 TNF Blockers 64 Lupus Nephritis 64 NeurogesX Nasdaq NGSX 64 Cholesterol Drugs 64 Lexicon Pharmaceuticals Inc 64 Receives Positive 64 Agonist MABA program 64 ENLIGHT 64 Positive Opinion 64 Ovitrelle R Serostim 64 Patient Treated 64 Aflibercept 64 Nasdaq SGEN 64 RDYN 64 visit www.novabaypharma.com 64 commercializing oxidized glutathione 64 NASDAQ ZGEN 64 pipeline ImmunoGen collaborators 64 Inc EXEL 64 II Clinical Trial 64 www.cardiome.com 64 Phase Ib II 64 Amend Merger Agreement 64 BFRM 64 Supplemental Biologics License Application 64 fusion enhancers 64 Inc. OTCBB ECTE 64 Revises FY# Outlook 64 www.vical.com 64 NasdaqCM PSTI DAX PJT 64 Gene Mutation 64 MAGE A3 ASCI 64 Improved Survival 64 novel antimitotic agent 64 Newly Diagnosed Patients 64 NMT Medical Announces 64 Nasdaq SPPI 64 markets HP Acthar 64 Inc. Nasdaq INSM 64 Relapsed Refractory 64 MorphoSys AG FSE MOR 64 WeissComm Partners +#-#-#-# 64 Board Unanimously Rejects 64 Consulting Fees Honoraria 64 Corp. www.anavex.com 64 Romidepsin 64 Arthritis Drugs 64 novel orally inhaled 64 Inc. NASDAQ ICGN 64 LAB CGRP 64 Inhibits 64 number NCT# ClinicalTrials.gov 64 Patents Covering 64 using VIAdel TM 64 Provides Clarification 64 Circulating Tumor Cells 64 Advancing Drugs 64 LWLG 64 Momenta Pharmaceuticals MNTA 64 Oral Insulin Capsule 64 Clinical Outcome 64 Bone Metastases 64 includes VIAtab TM 64 Inc. NASDAQ QLTI 64 novel VDA molecule 64 Cervical Cancer Vaccine 64 Bristol Myers Squibb sanofi 64 Pandemic Influenza Vaccine 64 euro adhoc Intercell AG 64 Diagnostic Tests 64 TKPHF 64 NYSE Amex BTX 64 Declares Qtr 64 Exclusive License 64 successfully commercialize Iluvien 64 http:/www.nastech.com 64 Kidney Transplant Patients 64 Boosts Qtr 64 OTCBB IMNR 64 LymphoStat B TM 64 MKC# MKC# PP 64 Crucell NV NYSE Euronext 64 cMET 64 developing Bicifadine serotonin 64 Upcoming Deadline 64 Testosterone MDTS ® 64 Bristol Myers Squibb Celgene 64 Enlarged Prostate 64 Company NASDAQ OMRI 64 Pluristem Therapeutics 64 www.vicortech.com 64 Nasdaq MITI 64 Guidelines Recommend